As I have mentioned in prior postings, one of my tasks this year as AIPLA President is to represent U.S. intellectual property interests around the world. (By the way, I learned that people in some South American countries pronounce our country’s U.S.A. initials as a word, such as asking “Are you from Ooh-SAh?”) There are a number of issues that keep coming up in discussion, but the one I’d like to focus on today is “patent attorneys” and privilege.
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works